Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
Erectile dysfunction (ED) affects over 50% of men aged 40 and older, resulting in pervasive impact on men's sexual health. Emerging research and market trends suggest a potential role for discreet ED treatments, underscoring the importance of patients' privacy, comfort and convenience. ETOBICOKE, ON Sept. 30, 2024 /CNW/ -- Viatris, a global healthcare company, today announced the launch of Pr Viagra ® ODF (sildenafil citrate orodispersible film) in Canada – a new form of the erectile dysfunction treatment, that dissolves in the mouth. This new solution underscores Viatris Canada's commitment to expanding options for the treatment for erectile dysfunction (ED). For the last 25 years in Canada , Viagra has supported the management of ED. Recognizing the psychological and social impact of ED , Viatris now introduces the new Viagra ODF. Viagra ODF dissolves in the mouth with or without water, providing a convenient dosage form. Features of Viagra ODF Viagra ODF delivers the pro
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe [Yahoo! Finance]Yahoo! Finance
- Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and EuropePR Newswire
- Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
- Viatris 2023 Sustainability Report: Reducing Packaging Material [Yahoo! Finance]Yahoo! Finance
- Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD) [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 8/8/24 - Beat
VTRS
Sec Filings
- 9/27/24 - Form 8-K
- 9/13/24 - Form 4
- 9/4/24 - Form 8-K
- VTRS's page on the SEC website